1599-高内皮静脉通过ALOX12驱动淋巴结肿瘤免疫逃逸 episode artwork

EPISODE · Sep 22, 2026 · 19 MIN

1599-高内皮静脉通过ALOX12驱动淋巴结肿瘤免疫逃逸

from 聊聊Sci

这项研究揭示了肿瘤细胞如何利用淋巴结中的高内皮静脉(HEV)实现免疫逃逸并向全身扩散。研究发现,肿瘤细胞通过分泌SEMA3C蛋白诱导HEV表达ALOX12酶,进而产生代谢物12-HETE。这种代谢分子能够促使肿瘤细胞内的ADAR1 p150蛋白与双链RNA发生液-液相分离,通过增强A-to-I RNA编辑来掩盖免疫信号,从而抑制干扰素反应。最终,从这些特殊血管进入循环的癌细胞具备了更强的抗免疫识别能力,显著增加了远端转移的风险。临床数据证实,HEV受累是乳腺癌患者预后不良的独立预测指标,为癌症治疗提供了潜在的新靶点。References:Xia Q, Pan J, Weng X, et al. Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12[J]. Nature Communications, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Sep 22, 2026

Embed this episode

Ready to play

1599-高内皮静脉通过ALOX12驱动淋巴结肿瘤免疫逃逸

0:00 19:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 19 minutes long.

When was this 聊聊Sci episode published?

This episode was published on September 22, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!